The image shows the Biovectra logo with the tagline "A part of Agilent," featuring geometric shapes in blue, yellow, and text in purple and black.

We Are Attending Phacilitate's Advanced Therapies Week

Meet with BIOVECTRA in San Diego
February 9-12, 2026

BIOVECTRA’s state-of-the-art Biomanufacturing and Vaccine Center has:

  • mRNA, pDNA, LNP formulation, & fill/finish manufacturing capabilities
  • 36,000 sq. ft of cGMP-compliant manufacturing space
  • a team of specialists dedicated to nucleic acid product manufacturing 
  • end-to-end efficiency with clinical through commercial supply

BIOVECTRA is a North American CDMO specializing in the clinical-to-commercial scale production of high-quality regulated APIs and intermediates, including:

  • Fermentation & Biologics
  • Small Molecule Synthesis
  • Peptide & Small Molecule Purification
  • pDNA, mRNA & LNP 
  • Highly Potent APIs
  • Bioreagents
  • Fill/Finish
  • Cell Banking
  • Gene Editing

Our team – backed by 50+ years of experience – looks forward to the opportunity to put our flexible, innovative manufacturing solutions at your disposal.

ATW-Logo

Meet With Us

Schedule a meeting with us and discover how we can support your projects and solve your most complex challenges.

SEO plus – Test

  • 20+ years at GSK, leading R&D activities on multiple vaccine programs
  • Recently held positions in industry include: Senior Director (Function Head), Protein Biochemistry; Director, Antigen Design & Prototype Production; and, Associate Director, Antigen Design and Protein Characterization.
  • Key areas of expertise are:
    • Process development of protein Biologics/Recombinant Antigens
    • Recombinant protein expression (mammalian, insect, yeast, bacterial)
    • Production/design of Viral Vectors, mRNA vaccines, Bacterial outer membrane vesicles
    • Protein Engineering and Structural Biology
    • Defining quality attributes, biophysical characterization of proteins, and analytical strategy
  • Post graduate degrees in Functional Genomics (Université Laval) and Bioinformatics (MIT); M. Sc. Microbiology and Immunology (Laval).
  • 25+ Patent & 5 Scientific Publications